2023 Was a troublesome year for that biopharma industry, with many corporations downsizing and restructuring their workforces to remain afloat. You will find signs of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and daily life sciences marketplace during the latter part of 2023 and have continued their https://sites.google.com/view/bio-sites/blog